Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Head and Neck Cancer

  Free Subscription


09.05.2022

1 Ann Thorac Surg
13 Anticancer Res
1 BMC Surg
1 Br J Oral Maxillofac Surg
1 Clin Cancer Res
1 Clin Nucl Med
10 Head Neck
4 J Clin Oncol
1 J Laryngol Otol
1 J Nucl Med
1 Nat Rev Cancer
9 Oral Oncol
4 Otolaryngol Head Neck Surg
7 PLoS One
1 Radiother Oncol
1 Surgery
8 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Thorac Surg

  1. KENT J, Erwin P, Haraf D, Liao CY, et al
    Laryngotracheal resection after B-Raf proto-oncogene inhibition for anaplastic thyroid carcinoma.
    Ann Thorac Surg. 2022 Apr 30. pii: S0003-4975(22)00666.
    PubMed         Abstract available


    Anticancer Res

  2. HUANG TS, Lee JJ, Huang SY, Cheng SP, et al
    Regulation of Expression of Sterol Regulatory Element-binding Protein 1 in Thyroid Cancer Cells.
    Anticancer Res. 2022;42:2487-2493.
    PubMed         Abstract available

  3. KLIMAITE R, Kazokaite M, Kondrotiene A, Dauksiene D, et al
    Diagnostic Value of Circulating Cell-free DNA in Patients With Papillary Thyroid Cancer.
    Anticancer Res. 2022;42:2289-2299.
    PubMed         Abstract available

  4. SUOJANEN J, Kainulainen S, Tarvainen L, Tornwall J, et al
    Handgrip Strength Predicts Poorly the Surgical Outcome or Length of Hospitalization in Patients With Surgically Operated Oral Cancer.
    Anticancer Res. 2022;42:2771-2774.
    PubMed         Abstract available

  5. OKAMOTO K, Ninomiya I, Saito H, Shimada M, et al
    Usefulness of Prophylactic Administration of Pegfilgrastim for Esophageal Cancer Chemotherapy: A Single-center Retrospective Study.
    Anticancer Res. 2022;42:2783-2790.
    PubMed         Abstract available

  6. EMI M, Hmai Y, Yoshikawa T, Hirohata R, et al
    Clinical Outcomes of Esophagectomy and Chemoradiotherapy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2022;42:2791-2795.
    PubMed         Abstract available

  7. KUNTE S, Sharett J, Wei W, Nasr C, et al
    Poorly Differentiated Thyroid Carcinoma: Single Institution Series of Outcomes.
    Anticancer Res. 2022;42:2531-2539.
    PubMed         Abstract available

  8. WARWAS B, Cremers F, Gerull K, Leichtle A, et al
    Risk Factors for Xerostomia Following Radiotherapy of Head-and-Neck Cancers.
    Anticancer Res. 2022;42:2657-2663.
    PubMed         Abstract available

  9. KATO T, Oshikiri T, Goto H, Sawada R, et al
    Impact of the Platelet-to-Lymphocyte Ratio as a Biomarker for Esophageal Squamous Cell Carcinoma.
    Anticancer Res. 2022;42:2775-2782.
    PubMed         Abstract available

  10. ACHILLA C, Papavramidis T, Angelis L, Chatzikyriakidou A, et al
    The Implication of X-Linked Genetic Polymorphisms in Susceptibility and Sexual Dimorphism of Cancer.
    Anticancer Res. 2022;42:2261-2276.
    PubMed         Abstract available

  11. DOLL C, Steffen C, Beck-Broichsitter B, Richter M, et al
    The Prognostic Significance of p16 and its Role as a Surrogate Marker for Human Papilloma Virus in Oral Squamous Cell Carcinoma: An Analysis of 281 Cases.
    Anticancer Res. 2022;42:2405-2413.
    PubMed         Abstract available

  12. KAJIKAWA H, Hirata M, Haruna M, Ueyama A, et al
    Tumor-infiltrating ICOS(+) Effector Regulatory T-Cells in Oral Squamous Cell Carcinoma as a Promising Biomarker for Prognosis and 'Hot' Tumor.
    Anticancer Res. 2022;42:2383-2393.
    PubMed         Abstract available

  13. AOYAMA T, Ju M, Komori K, Tamagawa H, et al
    The Systemic Inflammation Score Is an Independent Prognostic Factor for Esophageal Cancer Patients who Receive Curative Treatment.
    Anticancer Res. 2022;42:2711-2717.
    PubMed         Abstract available

  14. WONGPANUWICH W, Yodsanga S, Chaisuparat R, Amornphimoltham P, et al
    Association Between PD-L1 and Histatin1, 3 Expression in Advanced Head and Neck Squamous Cell Carcinoma.
    Anticancer Res. 2022;42:2689-2699.
    PubMed         Abstract available


    BMC Surg

  15. SHISHIDO Y, Matsunaga T, Makinoya M, Miyauchi W, et al
    Circular stapling anastomosis with indocyanine green fluorescence imaging for cervical esophagogastric anastomosis after thoracoscopic esophagectomy: a propensity score-matched analysis.
    BMC Surg. 2022;22:152.
    PubMed         Abstract available


    Br J Oral Maxillofac Surg

  16. SMEETS M, Van Dessel J, Croonenborghs TM, Politis C, et al
    Retrospective study on the predictive factors in chronic trismus.
    Br J Oral Maxillofac Surg. 2022;60:183-189.
    PubMed         Abstract available


    Clin Cancer Res

  17. DENEKA AY, Baca Y, Serebriiskii IG, Nicolas E, et al
    Association of TP53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck Cancer.
    Clin Cancer Res. 2022;28:1925-1937.
    PubMed         Abstract available


    Clin Nucl Med

  18. BALLAL S, Yadav MP, Moon ES, Rosch F, et al
    First-in-Human Experience With 177Lu-DOTAGA.(SA.FAPi)2 Therapy in an Uncommon Case of Aggressive Medullary Thyroid Carcinoma Clinically Mimicking as Anaplastic Thyroid Cancer.
    Clin Nucl Med. 2022;47:e444-e445.
    PubMed         Abstract available


    Head Neck

  19. NASSIF SJ, Sasani AR, Faller GT, Harb JL, et al
    Milan system for reporting salivary gland cytopathology: Adoption and outcomes in a community setting.
    Head Neck. 2022;44:1462-1467.
    PubMed         Abstract available

  20. MAO M, Qiu K, Ren J, Zhao Y, et al
    The revised Pittsburgh staging system for middle ear squamous cell carcinoma: A challenging clinical dilemma.
    Head Neck. 2022 Apr 5. doi: 10.1002/hed.27047.
    PubMed        

  21. ABU-SHAMA Y, Renard S, Nguyen DT, Henrot P, et al
    Descriptive analysis of recurrences of nasal intestinal-type adenocarcinomas after radiotherapy.
    Head Neck. 2022;44:1356-1367.
    PubMed         Abstract available

  22. KUSAFUKA K, Sato Y, Nakatani E, Baba S, et al
    The implicated clinical factors for outcomes in 304 patients with salivary duct carcinoma: Multi-institutional retrospective analysis in Japan.
    Head Neck. 2022;44:1430-1441.
    PubMed         Abstract available

  23. PAIK C, Osterbauer B, Sahyouni G, Park S, et al
    Thyroid tumor ratio: Improving the assessment of the impact of size in pediatric thyroid cancer.
    Head Neck. 2022;44:1342-1348.
    PubMed         Abstract available

  24. BLASCO MA, Noel CW, Truong T, Huang SH, et al
    Radiologic-pathologic correlation of major versus minor extranodal extension in oral cavity cancer.
    Head Neck. 2022;44:1422-1429.
    PubMed         Abstract available

  25. KATZ AP, Larkin R, Cohen ER, Franzmann E, et al
    Indications and outcomes for elective dissection of level V in primary parotid cancer.
    Head Neck. 2022;44:1349-1355.
    PubMed         Abstract available

  26. SHONKA DC JR, Ho A, Chintakuntlawar AV, Geiger JL, et al
    American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment.
    Head Neck. 2022;44:1277-1300.
    PubMed         Abstract available

  27. ELSERAGY A, Bello IO, Wahab A, Coletta RD, et al
    Emerging histopathologic markers in early-stage oral tongue cancer: A systematic review and meta-analysis.
    Head Neck. 2022;44:1481-1491.
    PubMed         Abstract available

  28. FORMAN R, Deshpande H, Burtness B, Bhatia AK, et al
    Efficacy and toxicity of weekly paclitaxel, carboplatin, and cetuximab as induction chemotherapy or in cases of metastases or relapse for head and neck cancer with a focus on elderly or frail patients.
    Head Neck. 2022 Apr 30. doi: 10.1002/hed.27077.
    PubMed         Abstract available


    J Clin Oncol

  29. NICHOLS AC, Theurer J, Prisman E, Read N, et al
    Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial.
    J Clin Oncol. 2022;40:866-875.
    PubMed         Abstract available

  30. MOWERY YM, Salama JK
    Interpreting ORATOR: Lessons Learned From a Randomized Comparison of Primary Surgical and Radiation Approaches for Early-Stage Oropharyngeal Cancer.
    J Clin Oncol. 2022;40:814-817.
    PubMed        

  31. FAGIN JA
    Age of Onset of Receptor Tyrosine Kinase Fusions Drives Distinct Biologic Outcomes in Thyroid Cancer.
    J Clin Oncol. 2022;40:1124-1126.
    PubMed        

  32. FERRIS RL, Burtness B, Flamand Y
    Reply to A.S. Garden.
    J Clin Oncol. 2022;40:1133-1134.
    PubMed        


    J Laryngol Otol

  33. FISHER EW, Fishman J
    Necrotising otitis externa, turbinate surgery, tonsillotomy, and care of octogenarian head and neck cancer patients.
    J Laryngol Otol. 2022;136:377-378.
    PubMed        


    J Nucl Med

  34. VERHOEFF SR, van de Donk PP, Aarntzen EHJG, Oosting SF, et al
    (89)Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
    J Nucl Med. 2022 May 5. pii: jnumed.121.263470. doi: 10.2967/jnumed.121.263470.
    PubMed         Abstract available


    Nat Rev Cancer


  35. Expanding oesophageal cancer research and care in eastern Africa.
    Nat Rev Cancer. 2022;22:253-254.
    PubMed        


    Oral Oncol

  36. SWARTZ JE, Smits HJG, Philippens MEP, de Bree R, et al
    Correlation and colocalization of HIF-1alpha and pimonidazole staining for hypoxia in laryngeal squamous cell carcinomas: A digital, single-cell-based analysis.
    Oral Oncol. 2022;128:105862.
    PubMed         Abstract available

  37. YEOM S, Jung EK, Lee DH, Lee JK, et al
    Clinical features and recurrence factors of benign neoplasms of the tongue base.
    Oral Oncol. 2022;128:105866.
    PubMed         Abstract available

  38. COUTU B, Ryan E, Christensen D, Lawrence E, et al
    Positive margins matter regardless of subsequent resection findings.
    Oral Oncol. 2022;128:105850.
    PubMed         Abstract available

  39. MULLER RG, Hamill CS, Vu B, Thuener J, et al
    Impact of AJCC 8th edition staging system and definitive treatment choice on the prognosis of complete responders with p16+ and p16- oropharyngeal squamous cell carcinomas.
    Oral Oncol. 2022;128:105861.
    PubMed         Abstract available

  40. MOLNAR K, Hietanen S, Liisanantti J, Koivunen P, et al
    Quality of life after free flap reconstruction for the cancer of the head and neck: Comparison between five-year survivors and non-survivors.
    Oral Oncol. 2022;128:105855.
    PubMed         Abstract available

  41. TRANCHITO E, Cabrera C, Terry M, Li S, et al
    Occult nodal metastasis in major salivary gland malignancy: An update from the National Cancer Database.
    Oral Oncol. 2022;128:105829.
    PubMed         Abstract available

  42. WEN X, Hu Y, Liu Y, Li Z, et al
    Conservative treatment of head and neck lymphoma is not the only effective treatment: A retrospective analysis of 301 cases.
    Oral Oncol. 2022;128:105828.
    PubMed         Abstract available

  43. MATTOX AK, D'Souza G, Khan Z, Allen H, et al
    Comparison of next generation sequencing, droplet digital PCR, and quantitative real-time PCR for the earlier detection and quantification of HPV in HPV-positive oropharyngeal cancer.
    Oral Oncol. 2022;128:105805.
    PubMed         Abstract available

  44. GALLOGLY JA JR, Weber AK, Mazul AL, Brinkmeier JV, et al
    Inferior outcomes associated with emergency department presentation for head and neck cancer surgery.
    Oral Oncol. 2022;129:105894.
    PubMed         Abstract available


    Otolaryngol Head Neck Surg

  45. KIM DH, Lee MH, Lee S, Kim SW, et al
    Comparison of Narrowband Imaging and White-Light Endoscopy for Diagnosis and Screening of Nasopharyngeal Cancer.
    Otolaryngol Head Neck Surg. 2022;166:795-801.
    PubMed         Abstract available

  46. BOLLIG CA, Wang K, Llerena P, Puram SV, et al
    National Analysis of Oropharyngeal Salivary Gland Malignancies Treated With Transoral Robotic Surgery.
    Otolaryngol Head Neck Surg. 2022;166:886-893.
    PubMed         Abstract available

  47. GO BC, Go CC, Chorath K, Moreira A, et al
    Multimodal Analgesia in Head and Neck Free Flap Reconstruction: A Systematic Review.
    Otolaryngol Head Neck Surg. 2022;166:820-831.
    PubMed         Abstract available

  48. COHEN JT, Goldman T, Paker M, Fridman E, et al
    Assessment of Early Stage Glottic Cancer Depth of Resection After Transoral Laser Cordectomy.
    Otolaryngol Head Neck Surg. 2022;166:901-906.
    PubMed         Abstract available


    PLoS One

  49. GRASS JK, Kusters N, Kemper M, Tintrup J, et al
    Risk stratification of cirrhotic patients undergoing esophagectomy for esophageal cancer: A single-centre experience.
    PLoS One. 2022;17:e0265093.
    PubMed         Abstract available

  50. JIN M, Jang A, Kim WG, Kim TY, et al
    Graves' disease diagnosed in remnant thyroid after lobectomy for thyroid cancer.
    PLoS One. 2022;17:e0265332.
    PubMed         Abstract available

  51. NIK JAAFAR NR, Hamdan NA, Abd Hamid N, Rajandram RK, et al
    Posttraumatic growth and its association with unmet supportive care needs and fear of cancer progression among head and neck cancer patients.
    PLoS One. 2022;17:e0265502.
    PubMed         Abstract available

  52. ZHANG ZJ, Shi LL, Hong XH, Xiao BY, et al
    A Bayesian network meta-analysis of the primary definitive therapies for locoregionally advanced nasopharyngeal carcinoma: IC+CCRT, CCRT+AC, and CCRT alone.
    PLoS One. 2022;17:e0265551.
    PubMed         Abstract available

  53. ALI A, Rumbold AR, Kapellas K, Lassi ZS, et al
    Association between self-reported periodontitis and high-risk oral human papillomavirus infection among Indigenous South Australians: A cross-sectional study.
    PLoS One. 2022;17:e0265840.
    PubMed         Abstract available

  54. XIE L, Shang Z
    Burden of oral cancer in Asia from 1990 to 2019: Estimates from the Global Burden of Disease 2019 study.
    PLoS One. 2022;17:e0265950.
    PubMed         Abstract available

  55. ELLIS BG, Whitley CA, Triantafyllou A, Gunning PJ, et al
    Prediction of malignant transformation in oral epithelial dysplasia using infrared absorbance spectra.
    PLoS One. 2022;17:e0266043.
    PubMed         Abstract available


    Radiother Oncol

  56. ZHAO Y, Liao X, Wang Y, Lan W, et al
    Level Ib CTV delineation in nasopharyngeal carcinoma based on lymph node distribution and topographic anatomy.
    Radiother Oncol. 2022 Apr 29. pii: S0167-8140(22)00232.
    PubMed         Abstract available


    Surgery

  57. PRASAD P, Wallace L, Navidi M, Phillips AW, et al
    Learning curves in minimally invasive esophagectomy: A systematic review and evaluation of benchmarking parameters.
    Surgery. 2022;171:1247-1256.
    PubMed         Abstract available


    Thyroid

  58. SHOBAB L, Burman KD, Wartofsky L
    Sex Differences in Differentiated Thyroid Cancer.
    Thyroid. 2021 Dec 31. doi: 10.1089/thy.2021.0361.
    PubMed         Abstract available

  59. MOLLEN K, Shaffer AD, Yip L, Monaco S, et al
    Unique Molecular Signatures are Associated with Aggressive Histology in Pediatric Differentiated Thyroid Cancer.
    Thyroid. 2021 Dec 16. doi: 10.1089/thy.2021.0317.
    PubMed         Abstract available

  60. KAO YH
    Letter to the Editor: Radioiodine Is Molecular Radiotherapy Governed by Predictable Deterministic Radiobiology Expressed in Gray, Not Millicuries.
    Thyroid. 2022;32:340-341.
    PubMed        

  61. PIERANNUNZIO D, Fedeli U, Francisci S, De Paoli A, et al
    Thyroidectomies in Italy: A population-based national analysis from 2001 to 2018.
    Thyroid. 2022 Jan 12. doi: 10.1089/thy.2021.0531.
    PubMed         Abstract available

  62. SAWKA AM, Ghai S, Rotstein L, Irish JC, et al
    A quantitative analysis examining patients' choice of active surveillance or surgery for managing low risk papillary thyroid cancer.
    Thyroid. 2022 Jan 12. doi: 10.1089/thy.2021.0485.
    PubMed         Abstract available

  63. TCHEKMEDYIAN V, Dunn L, Sherman EJ, Baxi SS, et al
    Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial.
    Thyroid. 2022 Jan 19. doi: 10.1089/thy.2021.0565.
    PubMed         Abstract available

  64. SIMOES-PEREIRA J, C Ferreira T, Limbert E, Cavaco BM, et al
    Response to "Radioiodine Is Molecular Radiotherapy Governed by Predictable Deterministic Radiobiology Expressed in Gray, Not Millicuries" by Kao.
    Thyroid. 2022;32:342-343.
    PubMed        

  65. MATSUURA D, Yuan A, Wang L, Ranganath R, et al
    Follicular and Hurthle Cell Carcinoma: Comparison of Clinicopathological Features and Clinical Outcomes.
    Thyroid. 2022;32:245-254.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: